Cepheid
Annamaria Vaszko serves as Vice President of Financial Planning and Analysis (FP&A) at Cepheid since January 2019, providing financial and business leadership while developing talent within the FP&A team. Previously, Annamaria held the position of VP Finance at Thermo Fisher Scientific during the integration of Affymetrix, and served as VP Finance & Corporate Controller at Affymetrix, overseeing various finance functions and managing a global team. Annamaria's career includes key financial roles at Extreme Networks, Hitachi Global Storage Technologies, and IBM, where responsibilities encompassed corporate accounting, financial planning, and analysis, as well as strategic business development. Annamaria is a CPA and holds a Master’s Degree in Economics from the University of Pécs.
Cepheid
9 followers
Cepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to Deoxyribonucleic acid (DNA) amplification and detection. The GeneXpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.